Cargando…
Merkel Cell Carcinoma with a Suppressor of Fused (SUFU) Mutation: Case Report and Potential Therapeutic Implications
INTRODUCTION: Merkel cell carcinoma is a neuroendocrine malignancy. Suppressor of fused (SUFU) is a tumor suppressor oncogene that participates in the Hedgehog (Hh) signaling pathway. The aim of the study was to describe a patient whose Merkel cell carcinoma demonstrated a SUFU genomic alteration. C...
Autores principales: | Cohen, Philip R., Kurzrock, Razelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470960/ https://www.ncbi.nlm.nih.gov/pubmed/25876211 http://dx.doi.org/10.1007/s13555-015-0074-5 |
Ejemplares similares
-
The relevance of a suppressor of fused (SUFU) mutation in the diagnosis and treatment of Gorlin syndrome
por: Ogden, Taylor, et al.
Publicado: (2018) -
Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics
por: Cohen, Philip R., et al.
Publicado: (2016) -
Suppressor of fused (Sufu) promotes epithelial-mesenchymal transition (EMT) in cervical squamous cell carcinoma
por: Zhang, Ziyu, et al.
Publicado: (2017) -
microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu)
por: Long, Haixia, et al.
Publicado: (2015) -
Panfolliculoma in SUFU-mutated basal cell nevus syndrome
por: Abid, Areeba, et al.
Publicado: (2023)